Business · 15/07/2022
FDA Finalizes Guidance for Patient Labeling of Human Prescription Drugs and Biological Products
The U.S. Food and Drug Administration (FDA) has released a final guidance for the content and format of Instructions for Use (IFU) documents for human prescription drugs and biological products, aiming to ensure patients receive clear and concise instructions for safe and effective use.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →